FONTENOT JASON D. (SVP, Chief Scientific Officer) reported 1 transaction at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/29/2023ACC: 0001209191-23-047590
Officer· SVP, Chief Scientific Officer
Since Mar 2021
-1.03K
Net shares
Net seller
$792.33
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.03K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.03K
Price / share
$0.77
Trade value
$792.33
% of position
0.7%
8/25/2023
138.33K→137.30K
Total
Net shares
−1.03K
Net value
-$792.33
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2023 | F · Tax Withholding | −1.03K | $0.77 | $792.33 | 0.7% | 138.33K | 137.30K |
| Total | −1.03K | -$792.33 | ||||||
Derivative Transactions0
No derivative transactions reported